ManageCare orchestrates multiple sclerosis and neuroimmunology care where early treatment decisions define decades of outcomes. Our AI automates referral processing with MRI lesion and CSF data, coordinates disease-modifying therapy initiation and monitoring, manages infusion scheduling, and ensures relapse detection happens in days rather than months.
Automate the MS journey — from first demyelinating event through disease-modifying therapy and relapse surveillance
76%
Reduction in time to disease-modifying therapy initiation
93%
DMT infusion adherence rate
61%
Faster relapse detection through symptom monitoring
3.1x
Improvement in MRI surveillance compliance
MS patients face critical journey gaps — referrals lack MRI and CSF data, DMT initiation is delayed by authorization, infusion scheduling is fragmented, treatment monitoring for PML and other risks is inconsistent, and relapses go unreported between visits because patients normalize their symptoms.
Referrals for demyelinating events arrive without MRI images, radiology reports, or CSF analysis requiring weeks of data collection
DMT prior authorization requires extensive documentation and delays treatment initiation during a critical early window
Infusion scheduling across multi-week and multi-month cycles with pre-infusion lab requirements is unmanageable manually
JCV antibody monitoring for PML risk is inconsistently tracked, creating dangerous gaps in patient safety surveillance
Relapses develop gradually and patients normalize symptoms, going unreported for weeks until disability is established
Vaccination schedules must be completed before immunosuppressive DMTs, adding another coordination layer
Every workflow purpose-built for multiple sclerosis & neuroimmunology operations.
Referral intake with OCR extraction, patient matching, and insurance verification in under 3 minutes — extracting MRI lesion burden, CSF results including oligoclonal bands, prior DMT history, and relapse timeline
AI-driven scheduling matching patients to optimal slots based on disease activity urgency, DMT infusion timing cycles, MRI monitoring intervals, and JCV antibody testing schedules
Smart waitlist that fills cancellations within minutes via automated SMS and voice outreach — prioritizing patients with active relapses, high lesion burden, or pending DMT initiation
Pre-treatment prep automation — pre-infusion lab panels (CBC, LFTs, JCV), MRI scheduling coordination, vaccination completion before immunosuppression, and DMT consent education with compliance confirmation
Multi-channel patient engagement: reminders, confirmations, and prep instructions via SMS, voice, and portal — including symptom tracking prompts, infusion reminders, and new symptom reporting channels
Real-time relapse detection and disease activity monitoring with AI severity assessment and escalation — tracking patient-reported symptoms, MRI progression, disability scale changes, and infusion tolerance
Post-treatment AI triage with 91% first-call resolution — addressing new neurological symptoms, infusion reactions, injection site issues, fatigue management, and DMT side effect concerns
Automated MS surveillance and follow-up — zero patients lost to follow-up with scheduled MRIs, disability assessments, JCV monitoring, and DMT efficacy reviews at protocol-defined intervals
Specialized AI employees that handle these workflows autonomously.
Processes MS and neuroimmunology referrals by extracting MRI lesion data, CSF results, prior DMT history, and relapse timelines. Compiles DMT authorization documentation, flags high-activity disease for urgent treatment initiation, and coordinates vaccination status assessment.
Manages cyclical DMT infusion scheduling with pre-infusion lab coordination, MRI surveillance timing, and JCV monitoring intervals. Fills infusion cancellations by matching waitlisted patients based on disease activity and treatment urgency.
Delivers MS-specific symptom tracking prompts, infusion preparation reminders, and new symptom reporting channels via SMS, voice, and portal. Provides educational resources matched to disease stage and DMT type, and supports injection training for self-administered therapies.
Monitors patient-reported symptoms for early relapse detection using AI pattern recognition against known MS relapse signatures. Provides triage with 91% first-call resolution for DMT side effects, fatigue management, and new symptoms, escalating suspected relapses and PML-concerning symptoms for immediate evaluation.
Learn more about the platform, AI employees, and measurable outcomes powering modern healthcare practices.
See the autonomous agents that handle scheduling, referrals, care management, and more.
Learn MoreUnderstand the architecture, integrations, and security behind ManageCare.
Learn MoreDiscover solutions for scheduling, waitlists, prior auth, patient outreach, and beyond.
Learn MoreExplore how practices reduce scheduling delays, increase throughput, and cut referral leakage.
Learn MoreSee how ManageCare's AI employees can automate your most time-consuming workflows and unlock new revenue.